©2018 by Balanced Biotech. Proudly created with Wix.com

    Balanced Biotech, Inc. is an innovative clinical-stage biotechnology company based in the USA with an impressive platform of smart solutions, better drug delivery systems and technological advances; this is at the core of all that we do. We are focused on enhancing lives through the development, research and marketing of these cost effective, innovative drug delivery systems that offer several therapeutic solutions. The company will ensure the use of innovative thinking introduced in the manufacturing and sales of medicine in the treatment of acute and life-threatening diseases by unlocking the potential of a cutting-edge multifunctional transdermal carrier.


    The Business

    We are a talented group of entrepreneurs, scientists and engineers with groundbreaking ideas and technologies that will contribute towards a better tomorrow. We provide smart solutions for patients and their families and pride ourselves on our unparalleled dedication and passion for success.

    According to the MARKETSANDMARKETS report “Transdermal Second Delivery System Market – Global Forecast to 2022”, the global market for transdermal drug delivery systems (TDDS) in 2017 amounted to nearly $35.72 billion. By 2024, the TDDS market will be worth $81.46 billion. The average market growth is estimated at a record level of 12.5% per year.

    At Balanced Biotech, Inc. our vision is to transform how the world approaches the treatment of acute and life-threatening disease by utilizing one of the most efficient transdermal drug delivery applications developed to date. Our Patented proprietary carriers of active substances can also be used as a transport system for commonly used oncological, anti-inflammatory, analgesic drugs and many more, increasing their targeted effects by up to 10 times, reducing the drug dose by 10 times and radically minimizing the side effects of therapy.


    Our Focus

    Technology makes the difference, better drug delivery systems and technological advances  are at the core of all that we do at Balanced Biotech.  Thanks to the unique properties of the delivery system, it is possible to increase the bioavailability of active substances up to 10 times and enable active substances to penetrate through skin barriers up to several centimeters. Thanks to the unique formula, it is possible to reduce the doses of substances and at the same time to intensify their action. The effect is the acceleration of treatment with reduced side effects.



    Projects in Registration Phase

    MTC-Y-U1  Oncology

    MTC-Y-U1/NA Oncology

    Pre-clinical trials have shown great success to date.  If interested in learning more or investing please fill out the contact form below. Thank you.